IDE Produits
(Insulin-Degrading Enzyme (IDE))
Catégories
This gene encodes a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described but have not been experimentally verified.[provided by RefSeq, Sep 2009].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories IDE en vedette
IDE Anticorps
High quality antibodies with extensive validation data.
IDE Kits ELISA
Reliable ELISA kits for a wide range of species.
IDE Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
IDE recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Mouse, Rat
Application
WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro)
Validations
- (6)
- (2)
N° du produit
ABIN723680
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IHC, IP, ICC
Validations
- (8)
N° du produit
ABIN7434305
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Mouse
Application
WB, ELISA, IHC (p), IHC (fro)
Validations
- (1)
N° du produit
ABIN723665
Quantité
100 μL
Fiche technique
Fiche technique
IDE recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Competition ELISA
Validations
N° du produit
ABIN626493
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Rat
Analytical Method
Quantitative Competition ELISA
Validations
N° du produit
ABIN627221
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Rabbit
Analytical Method
Quantitative Competition ELISA
Validations
N° du produit
ABIN628383
Quantité
96 tests
Fiche technique
Fiche technique
IDE recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1307363
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1307365
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
HEK-293 Cells
Validations
- (1)
- (1)
N° du produit
ABIN2723516
Quantité
20 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits IDE
: "Protein-Bound Anthocyanin Compounds of Purple Sweet Potato Ameliorate Hyperglycemia by Regulating Hepatic Glucose Metabolism in High-Fat Diet/Streptozotocin-Induced Diabetic Mice." dans: Journal of agricultural and food chemistry, Vol. 68, Issue 6, pp. 1596-1608, (2020) (PubMed).: "Neuroprotective effect of ipriflavone against scopolamine-induced memory impairment in rats." dans: Psychopharmacology, Vol. 234, Issue 20, pp. 3037-3053, (2018) (PubMed).
: "Thymoquinone-rich fraction nanoemulsion (TQRFNE) decreases Aβ40 and Aβ42 levels by modulating APP processing, up-regulating IDE and LRP1, and down-regulating BACE1 and RAGE in response to high ..." dans: Biomedicine & pharmacotherapy, Vol. 95, pp. 780-788, (2018) (PubMed).
: "The Protective Effects of IGF-I against β-Amyloid-related Downregulation of Hippocampal Somatostatinergic System Involve Activation of Akt and Protein Kinase A." dans: Neuroscience, Vol. 374, pp. 104-118, (2018) (PubMed).
: "Reduction in Aβ-induced cell death in the hippocampus of 17β-estradiol-treated female rats is associated with an increase in IGF-I signaling and somatostatinergic tone." dans: Journal of neurochemistry, Vol. 135, Issue 6, pp. 1257-71, (2016) (PubMed).
: "Vitamin D3 intake as regulator of insulin degrading enzyme and insulin receptor phosphorylation in diabetic rats." dans: Biomedicine & pharmacotherapy, Vol. 85, pp. 155-159, (2016) (PubMed).
: "Analysis of the proteolysis of bioactive peptides using a peptidomics approach." dans: Nature protocols, Vol. 8, Issue 9, pp. 1730-42, (2013) (PubMed).
: "Promoting scientific standards in Germany." dans: Science (New York, N.Y.), Vol. 328, Issue 5976, pp. 307, (2010) (PubMed).
: "Complex formation between metabolic enzymes in tumor cells: unfolding the MDR1-IDE paradigm." dans: Molecular cancer therapeutics, Vol. 8, Issue 11, pp. 3171, (2009) (PubMed).
: "Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families." dans: The Journal of biological chemistry, Vol. 282, Issue 11, pp. 7825-32, (2007) (PubMed).
Synonymes et noms alternatifs relatifs à IDE
insulin degrading enzyme (IDE), insulin-degrading enzyme (ide), insulin-degrading enzyme (LOC591315), insulin-degrading enzyme (CC1G_01115), insulin-degrading enzyme (Bm1_26615), insulin-degrading enzyme (PTRG_10875), metallopeptidase (SJAG_01430), insulin-degrading enzyme (EBI_21700), insulin-degrading enzyme (VDBG_06702), insulin-degrading enzyme (LOAG_08082), insulin-degrading enzyme (PGTG_04982), insulin-degrading enzyme (Tsp_00424), insulin degrading enzyme (Ide), 1300012G03Rik, 4833415K22Rik, AA675336, AI507533, IDE, INSDEGM, INSULYSIN, zgc:162603Protein level used designations for IDE
- insulysin
- insulin-degrading enzyme
- insulin-degrading enzyme-like
- insulin protease
- insulinase
- Abeta-degrading protease
Vous êtes ici:
